Here’s what you should know: 1. The approval provides increased reimbursement in the outpatient setting. The pass-through program will become effective Jan. 1, 2019. 2. The remede system is an ...

MINNETONKA, Minn., July 10, 2019 /PRNewswire/ -- Respicardia, Inc., the manufacturer of the only FDA-approved active implantable device for the treatment of central sleep apnea (CSA), today announced ...

MINNETONKA, Minn., Respicardia, Inc., a medical technology company developing innovative therapies that improve cardiovascular health, today announced that the Centers for Medicare and Medicaid ...

Athens, 19 May 2014: A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the ...

The Valley Hospital announced that it is using a new implantable device to treat adult patients with central sleep apnea. The Remede System treats central sleep apnea by activating a nerve located in ...

The FDA approved an implantable device, Respicardia’s Remede System, which helps fight moderate to severe cases of central sleep apnea, a condition where the brain doesn’t send proper signals to the ...

‘Moderate to severe central sleep apnea and the health hazards that arise from it may have found a cure at last with a new implantable device, thus helping people with this condition to have a good ...

The US Food and Drug Administration (FDA) approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remede System is an implantable device ...

Dr. Bert Hansky performed the first implant at Klinikum Bielefeld in Bielefeld, Germany. Prof. Dr. Christoph Stellbrink is the site's principal investigator. "I am very happy with my experience with ...

A novel device implanted under the skin like a pacemaker successfully treats central sleep apnea (CSA) in heart failure patients, according to research. The implantable system improves sleep and heart ...

Respicardia �, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients ...

A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress ...